BIOS CAPITAL MANAGEMENT, LP
BIOS CAPITAL MANAGEMENT, LP is a Pre-seed, Seed, Series A, Series B and Series C+ fund in Central US, South US and Southeastern US writing $100K–$150K checks into Healthcare, healthcare-tech and medical-device.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, healthcare-tech, medical-device
- Check size
- $100K–$150K
- Invests in
- Central US, South US, Southeastern US
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2013
- Assets under management
- $250M
Thesis
BIOS Capital Management, founded in 2013, focuses on early-stage biotech and medical technology companies, targeting a capital gap where funding needs are too small for traditional venture capital and too large for angel investors. The firm aims to address the lack of venture funding in the Central, South, and Southeastern United States, regions they believe have overlooked, yet compelling science. BIOS takes an active role in the companies they invest in, often seeking board participation or control to influence operations and strategic direction. The BIOS team brings together expertise in hedge funds, private equity, clinical drug development, and public pharma/biotech analysis. They maintain an activist approach post-investment, helping companies realize their potential through merger, acquisition, or initial public offering (IPO).
Common questions
Does BIOS CAPITAL MANAGEMENT, LP invest at the Pre-seed stage?
Yes. BIOS CAPITAL MANAGEMENT, LP lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does BIOS CAPITAL MANAGEMENT, LP write?
BIOS CAPITAL MANAGEMENT, LP writes $100K–$150K checks.
Where does BIOS CAPITAL MANAGEMENT, LP invest?
BIOS CAPITAL MANAGEMENT, LP invests in Central US, South US and Southeastern US.